Inhibrx Biosciences, Inc. (INBX)
123.34
-0.59
(-0.48%)
USD |
NASDAQ |
Aug 28, 16:00
123.34
0.00 (0.00%)
After-Hours: 19:48
Inhibrx Biosciences Market Cap : 1.814B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 1.823B |
| August 26, 2026 | 1.844B |
| August 25, 2026 | 1.805B |
| August 24, 2026 | 1.544B |
| August 21, 2026 | 1.524B |
| August 20, 2026 | 1.458B |
| August 19, 2026 | 1.493B |
| August 18, 2026 | 1.392B |
| August 17, 2026 | 1.353B |
| August 14, 2026 | 1.300B |
| August 13, 2026 | 1.427B |
| August 12, 2026 | 1.447B |
| August 11, 2026 | 1.359B |
| August 10, 2026 | 1.360B |
| August 07, 2026 | 1.295B |
| August 06, 2026 | 1.253B |
| August 05, 2026 | 1.225B |
| August 04, 2026 | 1.220B |
| August 03, 2026 | 1.208B |
| July 31, 2026 | 1.199B |
| July 30, 2026 | 1.238B |
| July 29, 2026 | 1.158B |
| July 28, 2026 | 1.164B |
| July 27, 2026 | 1.204B |
| July 24, 2026 | 1.191B |
| Date | Value |
|---|---|
| July 23, 2026 | 1.242B |
| July 22, 2026 | 1.255B |
| July 21, 2026 | 1.280B |
| July 20, 2026 | 1.228B |
| July 17, 2026 | 1.277B |
| July 16, 2026 | 1.301B |
| July 15, 2026 | 1.332B |
| July 14, 2026 | 1.362B |
| July 13, 2026 | 1.346B |
| July 10, 2026 | 1.359B |
| July 09, 2026 | 1.517B |
| July 08, 2026 | 1.418B |
| July 07, 2026 | 1.472B |
| July 06, 2026 | 1.419B |
| July 02, 2026 | 1.425B |
| July 01, 2026 | 1.387B |
| June 30, 2026 | 1.384B |
| June 29, 2026 | 1.395B |
| June 26, 2026 | 1.385B |
| June 25, 2026 | 1.392B |
| June 24, 2026 | 1.390B |
| June 23, 2026 | 1.357B |
| June 22, 2026 | 1.363B |
| June 18, 2026 | 1.359B |
| June 17, 2026 | 1.376B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AnaptysBio, Inc. | 1.631B |
| 4D Molecular Therapeutics, Inc. | 809.99M |
| Design Therapeutics, Inc. | 944.96M |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 233.72B |
Market Cap Related Metrics
| Price | 123.34 |
| Earnings Yield | -7.20% |